Your session is about to expire
← Back to Search
Gastrointestinal Bleeding Peripheral Pulse Volume for Gastrointestinal Bleeding
N/A
Waitlist Available
Led By Andrew Storm, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
- Adults (age \>18yr) undergoing emergent endoscopy for active GI bleeding.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, approximately 2 hours post endoscopy
Awards & highlights
No Placebo-Only Group
Summary
The purpose and aim of this study are to compare changes in pulse volume to non-invasively predict active bleeding or high-risk stigmata in patients undergoing a gastrointestinal endoscopy to assess feasibility of the flow meter clinically.
Eligible Conditions
- Gastrointestinal Bleeding
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, approximately 2 hours post endoscopy
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, approximately 2 hours post endoscopy
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes in peripheral pulse volume with and without active bleeding
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Gastrointestinal Bleeding Peripheral Pulse VolumeExperimental Treatment1 Intervention
Subject undergoing an emergency endoscopic evaluation for active gastrointestinal bleeding will have their peripheral pulse volumes monitored using a pulse flowmeter throughout the procedure and 2 hours after the procedure.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,333 Previous Clinical Trials
3,060,162 Total Patients Enrolled
Andrew Storm, MDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
206 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger